Observational Pharmaco-Epidemiology Research & Analysis

Launched by EPIVIDIAN · Jan 22, 2019

Keywords

ClinConnect Summary

The Observational Pharmaco-Epidemiology Research & Analysis (OPERA) trial is studying how different treatments work for patients with chronic diseases, such as HIV/AIDS, liver diseases, and heart conditions, among others. The goal is to gather real-world data from patient visits to help improve healthcare decisions and understand how these treatments affect people, especially those with additional health challenges or from diverse backgrounds.

To participate in this study, patients need to be receiving treatment in practices that join the OPERA trial and have their treatment documented in the practice's electronic health records. If someone chooses not to take part, they can opt out. Participants can expect their treatment and health information to be used to help advance research and improve care for everyone with chronic diseases. This is an important step towards better understanding how to manage these conditions in everyday healthcare settings.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are treated in the practices who enroll and participate in the study
• • Patients whose treatment is documented in the practice's electronic health record system
• Exclusion Criteria:
• • Patients who opt out of OPERA